Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-03 Weston Claire Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2026-08-03 Kirkby Maxwell Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2026-06-18 Ye Weiguo Chief Operating Officer Option exercise +3,000 $0.75 $2K 703,000
2026-06-18 Ye Weiguo Chief Operating Officer Sale −3,000 $6.35 $19K 700,000
2026-06-18 Ye Weiguo Chief Operating Officer Option exercise · Stock Option (Right to Buy) −3,000 827,701
2026-06-11 Ye Weiguo Chief Operating Officer Option exercise +2,800 $0.75 $2K 702,800
2026-06-11 Ye Weiguo Chief Operating Officer Sale −2,800 $6.17 $17K 700,000
2026-06-11 Ye Weiguo Chief Operating Officer Option exercise · Stock Option (Right to Buy) −2,800 838,701
2026-06-10 Carmichael Gordon Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2026-06-10 Epstein David M. Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2026-06-10 Weng Dan Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2026-06-10 Parry Renate Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2026-06-10 Zhang Ping Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2026-06-10 Nussbaum Rodney L Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2026-06-10 Ye Weiguo Chief Operating Officer Option exercise +5,000 $0.75 $4K 705,000
2026-06-10 Ye Weiguo Chief Operating Officer Sale −5,000 $6.24 $31K 700,000
2026-06-10 Ye Weiguo Chief Operating Officer Option exercise · Stock Option (Right to Buy) −5,000 830,701
2026-06-10 Ye Weiguo Chief Operating Officer Option exercise +6,418 $0.75 $5K 706,418
2026-06-10 Ye Weiguo Chief Operating Officer Sale −6,418 $6.21 $40K 700,000
2026-06-10 Ye Weiguo Chief Operating Officer Option exercise · Stock Option (Right to Buy) −6,418 841,501

Page 1 of 17 · 328 trades